Clinical Trials Logo

ABPA clinical trials

View clinical trials related to ABPA.

Filter by:
  • None
  • Page 1

NCT ID: NCT04108962 Recruiting - Severe Asthma Clinical Trials

Benralizumab in the Treatment of Patients With Severe Asthma With ABPA

Start date: December 23, 2019
Phase: Phase 4
Study type: Interventional

Phase IV, open-label study will evaluate effects of Benralizumab in the treatment of severe asthma in patients with allergic bronchopulmonary aspergillosis

NCT ID: NCT03643185 Recruiting - ABPA Clinical Trials

Cytokine Profile of Allergic Bronchopulmonary Aspergillosis

Start date: December 2014
Phase:
Study type: Observational

The main aim of this study is to determine whether the levels of different inflammatory cytokines in the serum and BALF (bronchoalveolar lavage fluid) are relative to the severity and exacerbations of ABPA (allergic bronchopulmonary aspergillosis).

NCT ID: NCT02853175 Completed - Clinical trials for Pulmonary Cystic Fibrosis

Lung MRI and Allergic Broncho-pulmonary Aspergillosis in Cystic Fibrosis

MRAB
Start date: January 2014
Phase:
Study type: Observational

In this diagnostic study, the aim is at evaluating the diagnostic accuracy of MRI (Magnetic Resonance Imaging) to detect allergic broncho-pulmonary aspergillosis in patients with cystic fibrosis.